Description:

Study ID: 110948 Clinical Study ID: 110948 Study Title: Assessment of the effect of sumatriptan and naproxen sodium combination tablet, sumatriptan tablet, and naproxen sodium tablet treatment on blood pressure when administered intermittently for six months for the acute treatment of migraine attacks, with or without aura, in adults Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00792636 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed Generic Name: sumatriptan and naproxen sodium combination tablet Trade Name: sumatriptan tablet, naproxen sodium tablet Study Indication: Migraine Disorders

Keywords:
Versions (2) ▾
  1. 10/6/19
  2. 10/24/19
Copyright Holder:
GlaxoSmithKline
Uploaded on:

October 24, 2019

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Sumatriptan and Naproxen Sodium for Acute Treatment of Migraine Attacks; NCT00792636

Baseline

  1. StudyEvent: ODM
    1. Baseline
Administrative Data
Date of Visit/Assessment
Status T-SMBP
Eligibility Question
Baseline Failure
Pharmacogenetic (PGx) Research Withdrawal of Consent
Investigator Signature
Vital Signs
mmHg
mmHg
mmHg
mmHg
mmHg
mmHg
bpm
mmHg
mmHg
mmHg
mmHg
IHS Headache Classification
Migraine History
migraines
days
days
Medical Conditions
Cardiac Conditions
Endocrine Disorders
Other [insert study specific classification] Conditions
Baseline Risk Factors for CV Events
Previous Treatment for Migraine
Randomisation Number